Clinical Trial Update: Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial evaluating the combination of low-dose radiotherapy with concurrent chemotherapy, toripalimab, and tifcemalimab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tifcemalimab (tifcemalimab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sichuan University | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING